Testing effectiveness (Phase 2)UnknownNCT03469804
What this trial is testing
Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma
Who this might be right for
Kaposi SarcomaProgression, Disease
Assistance Publique - Hôpitaux de Paris 17